Pillar Pharmaceuticals I LP (CIK: 0001534425) EDGAR, Information, Filings... CompaniesBIO.Com

Pillar Pharmaceuticals I LP

Mailing address
C/O PILLAR INVEST OFFSHORE SAL, STARCO CENTER BLOC B FL3, OMAR DAOUK ST, BEIRUT, Cayman Islands, 2020-3313
Phone
0119611363362
State location
Lebanon
State of incorporation
Cayman Islands
Fiscal year end
December 31
SIC
N/A
Filings
N/A

Pillar Pharmaceuticals I LP (CIK: 0001534425) is an American company incorporated in the state of Lebanon. Head office is located at C/O PILLAR INVEST OFFSHORE SAL, STARCO CENTER BLOC B FL3, OMAR DAOUK ST, BEIRUT, Lebanon, 2020-3313. Work in the industry N/A. Pillar Pharmaceuticals I LP is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Pillar Pharmaceuticals I LP

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-20-222471 ( Act) Size: 236 KB	Aug-17-2020
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-20-135295 ( Act) Size: 243 KB	May-07-2020
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-20-005917 (34 Act) Size: 24 KB	Feb-26-2020	001-31918 20657050
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-027012 (34 Act) Size: 24 KB	Nov-08-2019	001-31918 191205303
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000899243-19-020986 (34 Act) Size: 18 KB	Aug-05-2019	001-31918 19998649
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-19-202533 ( Act) Size: 216 KB	Jul-25-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-18-022726 (34 Act) Size: 29 KB	Aug-17-2018	001-31918 181026705
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-17-011717 (34 Act) Size: 18 KB	May-03-2017	001-31918 17811302
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-17-010925 (34 Act) Size: 12 KB	Apr-26-2017	001-31918 17785629
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-16-032851 (34 Act) Size: 11 KB	Nov-07-2016	001-31918 161979381
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-16-738792 ( Act) Size: 217 KB	Oct-17-2016
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010065 (34 Act) Size: 22 KB	Dec-17-2015	001-31918 151294863
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-009800 (34 Act) Size: 33 KB	Dec-14-2015	001-31918 151287176
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-14-075984 (34 Act) Size: 39 KB	Dec-16-2014	001-31918 141290763
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-14-074765 (34 Act) Size: 46 KB	Dec-11-2014	001-31918 141282157
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-14-055864 (34 Act) Size: 19 KB	Sep-04-2014	001-31918 141083468
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-14-053170 (34 Act) Size: 17 KB	Aug-18-2014	001-31918 141050317
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-14-036754 (34 Act) Size: 27 KB	May-23-2014	001-31918 14867961
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-14-008912 (34 Act) Size: 15 KB	Feb-11-2014	001-31918 14591216
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-13-395375 ( Act) Size: 209 KB	Oct-09-2013

Recent 20 filings. View all Pillar Pharmaceuticals I LP filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Where is Pillar Pharmaceuticals I LP's headquarters?

Pillar Pharmaceuticals I LP is located in C/O PILLAR INVEST OFFSHORE SAL, STARCO CENTER BLOC B FL3, OMAR DAOUK ST, BEIRUT, Lebanon, 2020-3313.

What is the Pillar Pharmaceuticals I LP's website?

Pillar Pharmaceuticals I LP's website is unknown

Who invested in Pillar Pharmaceuticals I LP?

Updating!

How much funding has Pillar Pharmaceuticals I LP raised to date?

Updating!

When was the last funding round for Pillar Pharmaceuticals I LP?

Updating!

When was Pillar Pharmaceuticals I LP founded?

Updating!

Pillar Pharmaceuticals I LP overview
Pillar Pharmaceuticals I LP job
Pillar Pharmaceuticals I LP stock
Pillar Pharmaceuticals I LP ownership
Pillar Pharmaceuticals I LP CEO
Pillar Pharmaceuticals I LP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.